THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development and commercialization of cell therapies, has announced that Lorin Jeffry (Jeff) Randall has joined its board of directors, bringing the number of directors to six. Mr. Randall will also serve as a member of the audit committee. Dr. Hung will resign from the audit committee, but remain a member of the board of directors.
